UTAH CERTIFIED NURSE MIDWIFE (CNM) CERTIFICATION EXAMINATION –
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
Antepartum Care and Fetal Monitoring
Intrapartum and Postpartum Management
Neonatal Resuscitation and Newborn Assessment
Gynecology, Contraception, and Reproductive Health
Primary Care and Health Promotion Across the Lifespan
Pharmacology and Pharmacokinetics in Obstetrics and Gynecology
Professional, Legal, Ethical, and Regulatory Standards in Utah Practice
The Utah Certified Nurse Midwife Certification Examination is designed to evaluate the
comprehensive competency, clinical acumen, and professional readiness of candidates
seeking independent licensure to practice midwifery within the state. This rigorous
assessment rigorously tests core knowledge across antenatal, intrapartum, postpartum,
neonatal, and gynecological domains, as well as essential primary care management.
Utilizing a dynamic blend of direct multiple-choice inquiries and complex clinical scenarios,
the examination emphasizes evidence-based practice, real-world clinical decision-making,
patient safety, and strict adherence to Utah health regulations and statutory standards
governing advanced practice registered nursing.
,SECTION ONE: QUESTIONS 1–100
A 28-year-old G1P0 at 12 weeks gestation presents for a routine prenatal visit. She
has a history of well-controlled epilepsy treated with levetiracetam. Which of the
following is the most appropriate initial management step regarding her antiepileptic
therapy?
A. Discontinue levetiracetam immediately to prevent teratogenic effects on the fetus.
B. Switch her medication to valproic acid due to superior seizure control profiles in
pregnancy.
C. Continue the current dosage of levetiracetam and coordinate with her neurologist for
ongoing monitoring.
D. Double the current levetiracetam dose to account for increased renal clearance in the
first trimester.
🟢 C. Continue the current dosage of levetiracetam and coordinate with her neurologist for
ongoing monitoring.
🔴 Explanation: Abrupt cessation of antiepileptic drugs poses a severe risk of status
epilepticus, which is catastrophic for both maternal and fetal well-being. Levetiracetam has
a relatively favorable safety profile in pregnancy compared to older agents like valproic
acid, which is known for high teratogenic risks. Management should involve maintaining
therapeutic levels through interprofessional collaboration.
A Utah-licensed CNM is providing prenatal care to an uninsured patient at 24 weeks
gestation who expresses severe anxiety about the cost of labor and delivery. Which
, resource or program should the midwife primarily direct the patient toward to ensure
continuous coverage?
A. Utah Medicaid programs for pregnant women
B. Private commercial catastrophic insurance exchanges exclusively
C. Out-of-pocket sliding-scale hospital financial forgiveness contracts
D. Federal Medicare Part A enrollment portals
🟢 A. Utah Medicaid programs for pregnant women
🔴 Explanation: Utah Medicaid offers specific coverage pathways for pregnant individuals
who meet income guidelines, providing vital access to prenatal care, labor and delivery
services, and postpartum care without gaps. This ensures maternal and fetal safety and
regulatory compliance regarding healthcare access.
During a routine 36-week prenatal visit, a patient complains of persistent, severe
pruritus on her palms and soles that worsens at night, with no primary skin rash
observed. Laboratory evaluation reveals an elevated total serum bile acid level of 25
micromol/L. What is the most appropriate clinical action?
A. Reassure the patient that this is normal physiological pruritus gravidarum and prescribe
emollients.
B. Diagnose intrahepatic cholestasis of pregnancy and initiate ursodeoxycholic acid
alongside plans for timed delivery at 36 to 37 weeks.
C. Order a skin biopsy to rule out pemphigoid gestationis and defer medical therapy until
histological confirmation.
, D. Immediately perform an emergency cesarean section due to imminent fetal demise
within 24 hours.
🟢 B. Diagnose intrahepatic cholestasis of pregnancy and initiate ursodeoxycholic acid
alongside plans for timed delivery at 36 to 37 weeks.
🔴 Explanation: Pruritus of the palms and soles coupled with elevated serum bile acids
indicates intrahepatic cholestasis of pregnancy (ICP). ICP carries a significant risk of
sudden intrauterine fetal demise, necessitating ursodeoxycholic acid for symptom and bile
acid reduction, and planned delivery between 36 0/7 and 38 6/7 weeks depending on
severity.
A 32-year-old G2P1 at 10 weeks gestation presents with hyperemesis gravidarum
refractory to outpatient dietary modifications and doxylamine-pyridoxine therapy. She
has lost 7% of her pre-pregnancy weight and exhibits ketonuria. What is the next
best pharmacological step?
A. Immediate inpatient admission for permanent total parenteral nutrition (TPN).
B. Initiation of a dopamine antagonist such as metoclopramide or promethazine.
C. Prescribing high-dose systemic corticosteroids as a first-line outpatient therapy.
D. Advancing straight to surgical placement of a percutaneous endoscopic gastrostomy
(PEG) tube.
🟢 B. Initiation of a dopamine antagonist such as metoclopramide or promethazine.
🔴 Explanation: When first-line therapy (doxylamine and pyridoxine) fails in hyperemesis
gravidarum, the next step involves adding dopamine antagonists (such as
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
Antepartum Care and Fetal Monitoring
Intrapartum and Postpartum Management
Neonatal Resuscitation and Newborn Assessment
Gynecology, Contraception, and Reproductive Health
Primary Care and Health Promotion Across the Lifespan
Pharmacology and Pharmacokinetics in Obstetrics and Gynecology
Professional, Legal, Ethical, and Regulatory Standards in Utah Practice
The Utah Certified Nurse Midwife Certification Examination is designed to evaluate the
comprehensive competency, clinical acumen, and professional readiness of candidates
seeking independent licensure to practice midwifery within the state. This rigorous
assessment rigorously tests core knowledge across antenatal, intrapartum, postpartum,
neonatal, and gynecological domains, as well as essential primary care management.
Utilizing a dynamic blend of direct multiple-choice inquiries and complex clinical scenarios,
the examination emphasizes evidence-based practice, real-world clinical decision-making,
patient safety, and strict adherence to Utah health regulations and statutory standards
governing advanced practice registered nursing.
,SECTION ONE: QUESTIONS 1–100
A 28-year-old G1P0 at 12 weeks gestation presents for a routine prenatal visit. She
has a history of well-controlled epilepsy treated with levetiracetam. Which of the
following is the most appropriate initial management step regarding her antiepileptic
therapy?
A. Discontinue levetiracetam immediately to prevent teratogenic effects on the fetus.
B. Switch her medication to valproic acid due to superior seizure control profiles in
pregnancy.
C. Continue the current dosage of levetiracetam and coordinate with her neurologist for
ongoing monitoring.
D. Double the current levetiracetam dose to account for increased renal clearance in the
first trimester.
🟢 C. Continue the current dosage of levetiracetam and coordinate with her neurologist for
ongoing monitoring.
🔴 Explanation: Abrupt cessation of antiepileptic drugs poses a severe risk of status
epilepticus, which is catastrophic for both maternal and fetal well-being. Levetiracetam has
a relatively favorable safety profile in pregnancy compared to older agents like valproic
acid, which is known for high teratogenic risks. Management should involve maintaining
therapeutic levels through interprofessional collaboration.
A Utah-licensed CNM is providing prenatal care to an uninsured patient at 24 weeks
gestation who expresses severe anxiety about the cost of labor and delivery. Which
, resource or program should the midwife primarily direct the patient toward to ensure
continuous coverage?
A. Utah Medicaid programs for pregnant women
B. Private commercial catastrophic insurance exchanges exclusively
C. Out-of-pocket sliding-scale hospital financial forgiveness contracts
D. Federal Medicare Part A enrollment portals
🟢 A. Utah Medicaid programs for pregnant women
🔴 Explanation: Utah Medicaid offers specific coverage pathways for pregnant individuals
who meet income guidelines, providing vital access to prenatal care, labor and delivery
services, and postpartum care without gaps. This ensures maternal and fetal safety and
regulatory compliance regarding healthcare access.
During a routine 36-week prenatal visit, a patient complains of persistent, severe
pruritus on her palms and soles that worsens at night, with no primary skin rash
observed. Laboratory evaluation reveals an elevated total serum bile acid level of 25
micromol/L. What is the most appropriate clinical action?
A. Reassure the patient that this is normal physiological pruritus gravidarum and prescribe
emollients.
B. Diagnose intrahepatic cholestasis of pregnancy and initiate ursodeoxycholic acid
alongside plans for timed delivery at 36 to 37 weeks.
C. Order a skin biopsy to rule out pemphigoid gestationis and defer medical therapy until
histological confirmation.
, D. Immediately perform an emergency cesarean section due to imminent fetal demise
within 24 hours.
🟢 B. Diagnose intrahepatic cholestasis of pregnancy and initiate ursodeoxycholic acid
alongside plans for timed delivery at 36 to 37 weeks.
🔴 Explanation: Pruritus of the palms and soles coupled with elevated serum bile acids
indicates intrahepatic cholestasis of pregnancy (ICP). ICP carries a significant risk of
sudden intrauterine fetal demise, necessitating ursodeoxycholic acid for symptom and bile
acid reduction, and planned delivery between 36 0/7 and 38 6/7 weeks depending on
severity.
A 32-year-old G2P1 at 10 weeks gestation presents with hyperemesis gravidarum
refractory to outpatient dietary modifications and doxylamine-pyridoxine therapy. She
has lost 7% of her pre-pregnancy weight and exhibits ketonuria. What is the next
best pharmacological step?
A. Immediate inpatient admission for permanent total parenteral nutrition (TPN).
B. Initiation of a dopamine antagonist such as metoclopramide or promethazine.
C. Prescribing high-dose systemic corticosteroids as a first-line outpatient therapy.
D. Advancing straight to surgical placement of a percutaneous endoscopic gastrostomy
(PEG) tube.
🟢 B. Initiation of a dopamine antagonist such as metoclopramide or promethazine.
🔴 Explanation: When first-line therapy (doxylamine and pyridoxine) fails in hyperemesis
gravidarum, the next step involves adding dopamine antagonists (such as
